Basit öğe kaydını göster

Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome

dc.contributor.authorTefekli, A
dc.contributor.authorErol, H
dc.contributor.authorKoksal, T
dc.contributor.authorUsta, M
dc.contributor.authorKadioglu, A
dc.date.accessioned2021-03-06T10:03:32Z
dc.date.available2021-03-06T10:03:32Z
dc.date.issued2000
dc.identifier.citationKadioglu A., Tefekli A., Koksal T., Usta M., Erol H., "Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome", INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, cilt.12, ss.169-175, 2000
dc.identifier.issn0955-9930
dc.identifier.otherav_e88537d6-5e39-4ae3-be64-17cb37a360e8
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/152813
dc.identifier.urihttps://doi.org/10.1038/sj.ijir.3900519
dc.description.abstractAs recent clinical and animal studies have indicated, colchicine, with its anti-fibrotic, anti-mitotic and anti-inflammatory activities, has suppressive effects in the pathogenesis of Peyronie's disease.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectNefroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titleTreatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome
dc.typeMakale
dc.relation.journalINTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
dc.contributor.department, ,
dc.identifier.volume12
dc.identifier.issue3
dc.identifier.startpage169
dc.identifier.endpage175
dc.contributor.firstauthorID125793


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster